Clinical trials: Intervention for Nerve Agent Exposure
Intervention for Nerve Agent Exposure
First Time in Human Study of Protexia
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of Protexia, an experimental drug being developed to protect soldiers against the effects of nerve agents.
- Trial name
- NCT00744146
- Testing
- Protexia
- Where
- United States
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- PharmAthene, Inc.